Total Funding
24
44
Total FundingGrant raised
Growth Score 24 in past quarter
-1 pts
Heat Score 44 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
186188
DoriVac is a immunotherapy platform that develops cutting-edge cancer treatments with the use of DNA nanotechnology.
About the Company
DoriVac DNA origami platform enables the precise spacing and geometrical arrangement of adjuvant and antigen ligands on nanostructures for their investigation of in vitro immune cell culture and in vivo tumor models.
